#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	5296	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2698	457.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1741	1741	C	663	C,A	593,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9030	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3900	533.9	0	.	n	.	0	T695C	SNP	695	695	T	1368	1368	C	679	C,A,G	602,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9030	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3900	533.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2644	2644	C	687	C	620	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9030	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3900	533.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2718	2718	A	611	A	545	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9030	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3900	533.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3270	3270	C	615	C	554	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	620	folP	855	855	100.0	folP.l6.c4.ctg.1	1958	75.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1236	1238	AGC	89;90;88	A;G;C	87;88;85	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	1734	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3807	108.3	0	.	p	.	0	G95A	NONSYN	283	285	GGC	741	743	GCC	108;108;108	G;C;C,A	101;101;99,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	1734	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3807	108.3	1	SNP	p	S91F	1	.	.	271	273	TTC	729	731	TTC	101;101;101	T;T;C	92;88;94	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	586	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1988	70.7	1	SNP	p	G45D	0	.	.	133	135	GGC	825	827	GGC	144;146;146	G;G;C	130;130;130	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	366	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1585	54.1	0	.	n	.	0	A197.	DEL	197	197	A	869	869	A	136	A	116	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3330	106.5	1	SNP	p	D86N	0	.	.	256	258	GAC	654	656	GAC	108;108;113	G;A;C	89;70;88	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3330	106.5	1	SNP	p	R87W	0	.	.	259	261	CGT	657	659	CGT	115;115;119	C;G;T	93;77;90	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3330	106.5	1	SNP	p	S87R	1	.	.	259	261	CGT	657	659	CGT	115;115;119	C;G;T	93;77;90	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3330	106.5	1	SNP	p	R87I	0	.	.	259	261	CGT	657	659	CGT	115;115;119	C;G;T	93;77;90	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3330	106.5	1	SNP	p	S88P	0	.	.	262	264	TCC	660	662	TCC	119;119;118	T,C;C,T;C	90,1;99,3;104	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1382	parE	1986	1986	99.85	parE.l15.c4.ctg.1	3273	101.0	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1687	1689	TGC	131;132;132	T;G,C;C	111;121,1;115	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1382	parE	1986	1986	99.85	parE.l15.c4.ctg.1	3273	101.0	0	.	p	.	0	P456S	NONSYN	1366	1368	CCC	2035	2037	TCC	131;132;130	T;C;C	122;125;124	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1382	parE	1986	1986	99.85	parE.l15.c4.ctg.1	3273	101.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1897	1899	GGC	119;122;123	G;G;C	105;108;99	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1253	1255	CGT	152;156;158	C;G,T,A;T	135;137,1,1;135	penA.43.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1250	1252	TAG	158;158;158	T,G,C;A;G,T	132,2,1;144;144,1	penA.43.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1238	1240	CAC	153;153;153	C;A;C	138;135;138	penA.43.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1238	1240	CAC	153;153;153	C;A;C	138;135;138	penA.43.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	734	736	TGG	96;98;97	T;G;G,C	71;84;90,1	penA.43.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	A502V	1	.	.	1504	1506	GTG	680	682	CAC	80;78;79	C;A,C;C,A	71;58,2;69,1	penA.43.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	V502P	0	.	.	1504	1506	GTG	680	682	CAC	80;78;79	C;A,C;C,A	71;58,2;69,1	penA.43.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	557	559	CCG	73;74;74	C,G;C,A;G,A,C	67,1;67,2;65,3,2	penA.43.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	548	550	CCG	70;69;69	C;C,G;G	65;56,1;55	penA.43.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.001	penA.43.001	1	1	283	1210	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2747	102.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	530	532	GGC	68;66;66	G,C;G,C;C,G,A	52,3;46,2;52,2,1	penA.43.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1524	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3474	100.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1801	1803	CCG	166;165;165	C,G,A;C,G;G,C	128,2,1;140,1;104,4	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	728	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2395	72.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	698	700	GGC	63;63;64	G;G;C	60;60;59	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	728	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2395	72.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	880	880	C	64	C	45	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2331	96.6	0	.	p	.	0	A26T	NONSYN	76	78	GCC	744	746	ACC	105;107;110	A;C;C	91;96;100	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2331	96.6	0	.	p	.	0	D41K	NONSYN	121	123	GAC	789	791	AAA	130;130;128	A;A;A	120;120;118	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2331	96.6	0	.	p	.	0	G120R	NONSYN	358	360	GGC	1026	1028	AGG	137;137;136	A,C;G;G	124,1;125;124	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2331	96.6	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1227	1229	CGA	139;139;139	C;G;A	128;126;127	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2331	96.6	0	.	p	.	0	S189N	NONSYN	565	567	AGC	1233	1235	AAC	135;135;135	A;A;C,G	124;123;122,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2331	96.6	1	SNP	p	A121D	1	.	.	361	363	GAC	1029	1031	GAC	138;137;137	G;A;C,A	127;124;124,1	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	948	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2331	96.6	1	SNP	p	D121N	0	.	.	361	363	GAC	1029	1031	GAC	138;137;137	G;A;C,A	127;124;124,1	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	3114	rpoB	4179	4179	99.88	rpoB.l6.c4.ctg.1	5384	135.5	0	.	p	.	0	G248D	NONSYN	742	744	GGC	1294	1296	GAC	172;172;172	G;A;C,G,A	157;155;155,1,1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	3114	rpoB	4179	4179	99.88	rpoB.l6.c4.ctg.1	5384	135.5	0	.	p	.	0	E1175D	NONSYN	3523	3525	GAG	4075	4077	GAC	141;142;142	G;A,T;C,A	122;120,1;125,1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	3114	rpoB	4179	4179	99.88	rpoB.l6.c4.ctg.1	5384	135.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2209	2211	AAT	139;139;139	A;A;T	123;122;124	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	402	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1698	57.5	1	SNP	p	V57M	1	.	.	169	171	ATG	863	865	ATG	134;134;134	A;T;G	126;126;126	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	1544	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2881	119.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
